Results 121 to 130 of about 1,619,240 (186)

Oral Hypoglycemic Agents

New England Journal of Medicine, 1989
ORAL hypoglycemic agents are commonly prescribed drugs. In the United States they account for about 1 percent of all prescriptions.1 This review discusses the pharmacology, mechanisms of action, ef...
John A. Oates   +2 more
exaly   +3 more sources

Oral Hypoglycemic Agents in Pregnancy

Obstetrics and Gynecology Clinics of North America, 2011
Multiple studies have been published illustrating the use of oral hypoglycemic agents in pregnancy. Glyburide and metformin have been shown to be as effective as insulin for the treatment of gestational diabetes. Both are safe with breastfeeding. Although both glyburide and metformin appear safe for the treatment of type 2 diabetes mellitus, more ...
Jerrie S Refuerzo
exaly   +3 more sources

Conformational Analysis of Non-Sulfonylurea Hypoglycemic Agents of the Meglitinide Family

open access: yesBiochemical Pharmacology, 1995
Non-sulfonylurea hypoglycemic agents of the meglitinide family such as S3075, repaglinide, KAD-1229, and A-4166, were found to display a comparable U-shaped conformation by molecular modelling, with hydrophobic cycles placed at the extremity of each ...
Laurence Lins   +2 more
exaly   +2 more sources

Oral Hypoglycemic Agents

Primary Care: Clinics in Office Practice, 1977
Oral agents should not be used in the treatment of patients with asymptomatic maturity-onset diabetes. The indication for sulfonylureas is symptomatic maturity-onset diabetes or excessive hyperglycemia--fasting blood sugar over 300 mg per 100 ml--in the elderly patient who cannot or will not take insulin. The use of biguanides cannot be recommended.
  +8 more sources

Home - About - Disclaimer - Privacy